gefitinib has been researched along with andrographolide in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (andrographolide) | Trials (andrographolide) | Recent Studies (post-2010) (andrographolide) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 923 | 9 | 736 |
Protein | Taxonomy | gefitinib (IC50) | andrographolide (IC50) |
---|---|---|---|
Bile acid receptor | Homo sapiens (human) | 9.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, M; Digwal, CS; Pandya, AN; Pandya, DH; Patel, S; Sharma, JA; Vasu, KK | 1 |
1 other study(ies) available for gefitinib and andrographolide
Article | Year |
---|---|
Imidazo[1,2-a]pyridines linked with thiazoles/thiophene motif through keto spacer as potential cytotoxic agents and NF-κB inhibitors.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; HeLa Cells; Humans; NF-kappa B; Pyridines; Structure-Activity Relationship; Thiazoles; Thiophenes | 2017 |